208 related articles for article (PubMed ID: 20348391)
1. Long-term study of indolent adult T-cell leukemia-lymphoma.
Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
[TBL] [Abstract][Full Text] [Related]
3. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
[TBL] [Abstract][Full Text] [Related]
6. Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic types.
Taniguchi H; Imaizumi Y; Takasaki Y; Nakashima J; Kato T; Itonaga H; Sato S; Sawayama Y; Ando K; Hasegawa H; Hata T; Moriuchi Y; Tsukasaki K; Miyazaki Y
Int J Hematol; 2019 Apr; 109(4):402-408. PubMed ID: 30680667
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
[TBL] [Abstract][Full Text] [Related]
8. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Nasr R; Marçais A; Hermine O; Bazarbachi A
Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
[TBL] [Abstract][Full Text] [Related]
10. Treatment and survival among 1594 patients with ATL.
Katsuya H; Ishitsuka K; Utsunomiya A; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Amano M; Hino R; Shimokawa M; Kawai K; Suzumiya J; Tamura K;
Blood; 2015 Dec; 126(24):2570-7. PubMed ID: 26361794
[TBL] [Abstract][Full Text] [Related]
11. [Progress in the management of ATL].
Ishitsuka K
Rinsho Ketsueki; 2017; 58(6):676-682. PubMed ID: 28680001
[TBL] [Abstract][Full Text] [Related]
12. [Development of future treatment for ATL].
Ishitsuka K
Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
Kataoka K; Iwanaga M; Yasunaga JI; Nagata Y; Kitanaka A; Kameda T; Yoshimitsu M; Shiraishi Y; Sato-Otsubo A; Sanada M; Chiba K; Tanaka H; Ochi Y; Aoki K; Suzuki H; Shiozawa Y; Yoshizato T; Sato Y; Yoshida K; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Shide K; Kubuki Y; Hidaka T; Nakamaki T; Ishiyama K; Miyawaki S; Ishii R; Nureki O; Tobinai K; Miyazaki Y; Takaori-Kondo A; Shibata T; Miyano S; Ishitsuka K; Utsunomiya A; Shimoda K; Matsuoka M; Watanabe T; Ogawa S
Blood; 2018 Jan; 131(2):215-225. PubMed ID: 29084771
[TBL] [Abstract][Full Text] [Related]
14. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).
Leuk Res; 1991; 15(2-3):81-90. PubMed ID: 2016910
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Ishitsuka K; Tsukasaki K; Tamura K
Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
[TBL] [Abstract][Full Text] [Related]
16. Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K
Int J Hematol; 2023 Feb; 117(2):206-215. PubMed ID: 36308678
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.
Nakashima J; Imaizumi Y; Taniguchi H; Ando K; Iwanaga M; Itonaga H; Sato S; Sawayama Y; Hata T; Yoshida S; Moriuchi Y; Miyazaki Y
Int J Hematol; 2018 Nov; 108(5):516-523. PubMed ID: 30032392
[TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
[TBL] [Abstract][Full Text] [Related]
20. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma.
Matsushita K; Matsumoto T; Ohtsubo H; Fujiwara H; Imamura N; Hidaka S; Kukita T; Tei C; Matsumoto M; Arima N
Leuk Lymphoma; 1999 Dec; 36(1-2):67-75. PubMed ID: 10613451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
